The Philippines has fined Sanofi P100,000 and suspended clearance for the French drug maker’s controversial dengue vaccine Dengvaxia, citing violations on product registration and marketing, its health secretary said on Thursday. The French pharmaceutical vowed to cooperate with FDA.
Post a Comment